Notice of Availability of Government-Owned Inventions; Foreign Patent Rights Available, 50352 [2018-21606]

Download as PDF 50352 Federal Register / Vol. 83, No. 194 / Friday, October 5, 2018 / Notices Once one or more seams are separated, the needle body may be removed from the guide wire without the need to withdraw the needle along the length of the guide wire, which permits preloading of expanders and other medical devices onto the guidewire. Authority: 35 U.S.C. 209; 37 CFR 404. Henry Williams, Acting Air Force Federal Register Liaison Officer. Various movable elements are used to adjust an adjustable passageway to regulate controlled anterograde blood flow. Authority: 35 U.S.C. 209; 37 CFR 404. Henry Williams, Civ, DAF, Acting Air Force Federal Register Liaison Officer. [FR Doc. 2018–21606 Filed 10–4–18; 8:45 am] BILLING CODE 5001–10–P Department of the Air Force [Docket No. AFD 1507PCT] Department of the Air Force [Docket No. AFD 1563PCT] Notice of Availability of GovernmentOwned Inventions; Foreign Patent Rights Available Department of the Air Force, Department of Defense. ACTION: Notice of availability. AGENCY: daltland on DSKBBV9HB2PROD with NOTICES VerDate Sep<11>2014 17:11 Oct 04, 2018 Jkt 247001 Notice of Availability of GovernmentOwned Inventions; Foreign Patent Rights Available Department of the Air Force, Department of Defense. ACTION: Notice of availability AGENCY: Pursuant to the Bayh-Dole Act and implementing regulations, the Department of the Air Force hereby gives notice of availability of foreign patent rights associated with International Patent Application No. PCT/US17/037509, published as WO 2017/0222895, entitled BENDABLE, CREASABLE, AND PRINTABLE BATTERIES WITH ENHANCED SAFETY AND HIGH TEMPERATURE STABILITY—METHODS OF FABRICATION, AND METHODS OF USING THE SAME. ADDRESSES: Submit requests for information to the ORTA, Air Force Research Laboratory, Materials & Manufacturing Directorate (AFRL/RX), 2977 Hobson Way, Wright-Patterson AFB, OH 45433; Facsimile: (937) 656– 4831; or Ms. Sunita Chavan, (937) 904– 4635. Include Docket No. AFD 1507PCT in the subject line of the message. FOR FURTHER INFORMATION CONTACT: ORTA, Air Force Research Laboratory, Materials & Manufacturing Directorate (AFRL/RX), 2977 Hobson Way, WrightPatterson AFB, OH 45433; Facsimile: (937) 656–4831; Ms. Sunita Chavan (937) 904–4635; or Air Force Materiel Command Law Office, AFMCLO/JAZ, 2240 B Street, Rm. 260, WrightPatterson AFB, OH 45433–7109; Facsimile: (937) 255–3733; Email: afmclo.jaz.tech@us.af.mil. SUPPLEMENTARY INFORMATION: The claimed bendable, creasable, and printable battery technology includes novel formulations for composite electrolytes, and current collectors that are suitable for use in high temperature environments. SUMMARY: Pursuant to the Bayh-Dole Act and implementing regulations, the Department of the Air Force hereby gives notice of availability of foreign patent rights associated with International Patent Application No. PCT/US17/036023, published as WO 2017/0214069, entitled FLOW RATE CONTROL DEVICE FOR VARIABLE INTRA–AORTIC OCCLUSION. ADDRESSES: Submit requests for information to the ORTA, 60th MDG, 101 Bodin Circle, Travis AFB, CA 94535; Facsimile: (228) 376–0128; or Mr. John Tupin, (707) 423–7206. Include Docket No. AFD 1563PCT in the subject line of the message. FOR FURTHER INFORMATION CONTACT: ORTA, 60th MDG, 101 Bodin Circle, Travis AFB, CA 94535; Facsimile: (228) 376–0128; Mr. John Tupin, (707) 423– 7206; or Air Force Materiel Command Law Office, AFMCLO/JAZ, 2240 B Street, Rm. 260, Wright-Patterson AFB, OH 45433–7109; Facsimile: (937) 255– 3733; Email: afmclo.jaz.tech@us.af.mil. SUPPLEMENTARY INFORMATION: The claimed endovascular variable aortic control catheter is configured to augment upstream blood pressure and regulate downstream blood flow for patients in shock. The device includes a catheter-based system having a proximal hand piece for controlled deployment of the device through a delivery sheath. A collapsible, wire framework supports an expandable and collapsible occlusion barrier. The wire framework and occlusion barrier expand to fit within the lumen of the aorta. SUMMARY: PO 00000 Frm 00022 Fmt 4703 [FR Doc. 2018–21604 Filed 10–4–18; 8:45 am] BILLING CODE 5001–10–P DEPARTMENT OF DEFENSE Defense Advisory Committee on Investigation, Prosecution, and Defense of Sexual Assault in the Armed Forces; Notice of Federal Advisory Committee Meeting DEPARTMENT OF DEFENSE DEPARTMENT OF DEFENSE Henry Williams, Civ, DAF, Acting Air Force Federal Register Liaison Officer. Office of the Secretary [FR Doc. 2018–21603 Filed 10–4–18; 8:45 am] BILLING CODE 5001–10–P Authority: 35 U.S.C. 209; 37 CFR 404. Sfmt 4703 General Counsel of the Department of Defense, Department of Defense. ACTION: Notice of Federal Advisory Committee meeting. AGENCY: The Department of Defense (DoD) is publishing this notice to announce that the following Federal Advisory Committee meeting of the Defense Advisory Committee on Investigation, Prosecution, and Defense of Sexual Assault in the Armed Forces will take place. DATES: Open to the public, Friday, October 19, 2018 from 9:00 a.m. to 5:00 p.m. ADDRESSES: One Liberty Center, 875 N Randolph Street, Suite 1432, Arlington, Virginia 22203. FOR FURTHER INFORMATION CONTACT: Dwight Sullivan, 703–695–1055 (Voice), dwight.h.sullivan.civ@mail.mil (Email). Mailing address is DAC–IPAD, One Liberty Center, 875 N Randolph Street, Suite 150, Arlington, Virginia 22203. Website: https://dacipad.whs.mil/. The most up-to-date changes to the meeting agenda can be found on the website. SUPPLEMENTARY INFORMATION: This meeting is being held under the provisions of the Federal Advisory Committee Act (FACA) of 1972 (5 U.S.C., Appendix, as amended), the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended), and 41 CFR 102–3.140 and 102–3.150. Purpose of the Meeting: In section 546 of the National Defense Authorization Act for Fiscal Year 2015 (Pub. L. 113– 291), as modified by section 537 of the National Defense Authorization Act for Fiscal Year 2016 (Pub. L. 114–92), Congress tasked the DAC–IPAD to advise the Secretary of Defense on the investigation, prosecution, and defense of allegations of rape, forcible sodomy, sexual assault, and other sexual misconduct involving members of the Armed Forces. This will be the tenth SUMMARY: E:\FR\FM\05OCN1.SGM 05OCN1

Agencies

[Federal Register Volume 83, Number 194 (Friday, October 5, 2018)]
[Notices]
[Page 50352]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-21606]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Air Force

[Docket No. AFD 1563PCT]


Notice of Availability of Government-Owned Inventions; Foreign 
Patent Rights Available

AGENCY: Department of the Air Force, Department of Defense.

ACTION: Notice of availability.

-----------------------------------------------------------------------

SUMMARY: Pursuant to the Bayh-Dole Act and implementing regulations, 
the Department of the Air Force hereby gives notice of availability of 
foreign patent rights associated with International Patent Application 
No. PCT/US17/036023, published as WO 2017/0214069, entitled FLOW RATE 
CONTROL DEVICE FOR VARIABLE INTRA-AORTIC OCCLUSION.

ADDRESSES: Submit requests for information to the ORTA, 60th MDG, 101 
Bodin Circle, Travis AFB, CA 94535; Facsimile: (228) 376-0128; or Mr. 
John Tupin, (707) 423-7206. Include Docket No. AFD 1563PCT in the 
subject line of the message.

FOR FURTHER INFORMATION CONTACT: ORTA, 60th MDG, 101 Bodin Circle, 
Travis AFB, CA 94535; Facsimile: (228) 376-0128; Mr. John Tupin, (707) 
423-7206; or Air Force Materiel Command Law Office, AFMCLO/JAZ, 2240 B 
Street, Rm. 260, Wright-Patterson AFB, OH 45433-7109; Facsimile: (937) 
255-3733; Email: [email protected].

SUPPLEMENTARY INFORMATION: The claimed endovascular variable aortic 
control catheter is configured to augment upstream blood pressure and 
regulate downstream blood flow for patients in shock. The device 
includes a catheter-based system having a proximal hand piece for 
controlled deployment of the device through a delivery sheath. A 
collapsible, wire framework supports an expandable and collapsible 
occlusion barrier. The wire framework and occlusion barrier expand to 
fit within the lumen of the aorta. Various movable elements are used to 
adjust an adjustable passageway to regulate controlled anterograde 
blood flow.

    Authority:  35 U.S.C. 209; 37 CFR 404.

Henry Williams,
Civ, DAF, Acting Air Force Federal Register Liaison Officer.
[FR Doc. 2018-21606 Filed 10-4-18; 8:45 am]
 BILLING CODE 5001-10-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.